T‐cell antibody induction showed no clear difference in graft loss Graft loss (including death with a functioning graft) at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in acute rejection Number of participants who experienced at least 1… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in infection Number of participants who experienced at least 1 episode… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower cytomegalovirus infection Number of participants who experienced at… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in hepatitis C recurrence Number of participants diagnosed with… compared with corticosteroid induction (low certainty).
T‐cell antibody induction showed no clear difference in malignancy Number of participants diagnosed with a malignancy compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower diabetes mellitus Number of participants with new‐onset diabetes… compared with corticosteroid induction (low certainty).
T‐cell antibody induction may leads to lower mortality Mortality at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction may leads to lower graft loss including death Graft loss including death at latest compared with placebo/no intervention (low certainty).
T‐cell antibody induction probably leads to lower acute rejection Number of participants who experienced at least 1… compared with placebo/no intervention (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in mortality compared with interleukin‐2 receptor antagonist induction (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in acute rejection compared with interleukin‐2 receptor antagonist induction (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in infection compared with interleukin‐2 receptor antagonist induction (moderate certainty).
Polyclonal T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with interleukin‐2 receptor antagonist induction (moderate certainty).